Package 25021-246-02

Brand: thiotepa

Generic: thiotepa
NDC Package

Package Facts

Identity

Package NDC 25021-246-02
Digits Only 2502124602
Product NDC 25021-246
Description

1 VIAL in 1 CARTON (25021-246-02) / 1.5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2018-06-15
Brand thiotepa
Generic thiotepa
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRACAVITARY", "INTRAVENOUS", "INTRAVESICAL"], "spl_id": "94e38a38-8923-499d-bd75-f85754d7c730", "openfda": {"nui": ["N0000000236", "N0000175558"], "unii": ["905Z5W3GKH"], "rxcui": ["1660009"], "spl_set_id": ["448c29f1-6d9c-4f8e-8a69-9b85e973e728"], "pharm_class_epc": ["Alkylating Drug [EPC]"], "pharm_class_moa": ["Alkylating Activity [MoA]"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (25021-246-02)  / 1.5 mL in 1 VIAL", "package_ndc": "25021-246-02", "marketing_start_date": "20180615"}], "brand_name": "Thiotepa", "product_id": "25021-246_94e38a38-8923-499d-bd75-f85754d7c730", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Alkylating Activity [MoA]", "Alkylating Drug [EPC]"], "product_ndc": "25021-246", "generic_name": "Thiotepa", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Thiotepa", "active_ingredients": [{"name": "THIOTEPA", "strength": "15 mg/1.5mL"}], "application_number": "ANDA209150", "marketing_category": "ANDA", "marketing_start_date": "20180615", "listing_expiration_date": "20261231"}